Allianz Asset Management Gmb H Agenus Inc Transaction History

Allianz Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$1.45 - $2.95 $280,109 - $569,878	193,179 New	193,179 $293,000
Q2 2018 Aug 13, 2018	SELL	$2.26 - $4.65 $555,880 - $1.14 Million	-245,965 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$3.51 - $6.04 $51,365 - $88,389	14,634 Added 6.33%	245,965 $1.16 Million
Q4 2017 Feb 13, 2018	SELL	$3.26 - $4.78 $10,608 - $15,554	-3,254 Reduced 1.39%	231,331 $754,000
Q3 2017 Nov 13, 2017	SELL	$3.48 - $4.44 $6,469 - $8,253	-1,859 Reduced 0.79%	234,585 $1.04 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-4,846 Reduced 2.01%	236,444 $924,000
Q1 2017 Apr 17, 2019	SELL	N/A	-3,795 Reduced 1.55%	241,290 $910,000
Q4 2016 Apr 17, 2019	SELL	N/A	-41,887 Reduced 14.6%	245,085 $1.01 Million
Q3 2016 Apr 17, 2019	BUY	N/A	286,972	286,972 $2.06 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.